A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Bepotastine Besilate (Bepreve)

Bepotastine Besilate blocks histamine to relieve allergy symptoms like sneezing, itching, and runny nose.

First FDA approval2009-09-08
Generic availableYes · 4 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$16.6M in CY2024 Part D spend101K claims · 32K beneficiaries · 329 plans surveyed

Lowest NADAC
$13.03/unit
11 NDCs benchmarked, lowest of all strengths.
Average NADAC
$17.35
Across all dosage forms in distribution.
Highest NADAC
$55.94
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Bepotastine Besilate used for?

Bepotastine Besilate blocks histamine to relieve allergy symptoms like sneezing, itching, and runny nose.

Is there a generic for Bepotastine Besilate?

Yes. 4 ANDAs filed at FDA, 4 generic manufacturers currently shipping.

How much does my plan pay for Bepotastine Besilate?

Across 329 Part D plans, Bepotastine Besilate averages $17.35/unit (NADAC). Lowest available: $13.03/unit. Highest in distribution: $55.94/unit.

Is Bepotastine Besilate on the FDA shortage list?

No. Bepotastine Besilate is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Histamine-1 Receptor Antagonist6 alternatives in D1
01
Alcaftadine
Brand: LASTACAFT
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
02
Azelastine
Brand: Azelastine Hydrochloride
$0.286Lowest NADAC
10Generic mfrs
$131.8MCY24 Part D spend
Compare →
03
Azelastine and Fluticasone
Brand: DYMISTA
$2.26Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
04
Carbinoxamine
Brand: CARBZAH
$0.432Lowest NADAC
4Generic mfrs
$3.6MCY24 Part D spend
Compare →
05
Cetirizine
Brand: Cetirizine Hydrochloride
$0.021Lowest NADAC
9Generic mfrs
$5.5MCY24 Part D spend
Compare →
06
Desloratadine
Brand: Clarinex
$0.287Lowest NADAC
6Generic mfrs
$10.5MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (5 approvals on file) · NADAC unit costs: CMS NADAC weekly file (11 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.